Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

IMMPORT THERAPEUTICS INC

UEI: ZJAMPJY7M149CAGE: 4C5L7

IMMPORT THERAPEUTICS INC is a federal contractor, registered under UEI ZJAMPJY7M149 and CAGE code 4C5L7. It has been awarded $18,135,306 in federal contracts. Primary work spans Unknown NAICS, Research and Development in Biotechnology (except Nanobiotechnology), and Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Top awarding agencies include Department Of Health And Human Services, Department Of Health And Human Services (hhs), and Department Of Agriculture.

Contact Information

Registration and classification details

Phone+1 (555) 000-0000

Websitehttp://www.antigendiscovery.com

Address123 Main St, City, ST 12345

Registration

UEI Code

ZJAMPJY7M149

CAGE Code

4C5L7

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

541714Research and Development in Biotechnology (except Nanobiotechnology)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ImmPort Therapeutics Inc. specializes in early-stage biomedical research and development focused on antigen discovery and immunotherapeutic innovation, primarily supporting federal life sciences initiatives. The company leverages advanced molecular biology and immunoinformatics to identify and chara...

Key Performance Metrics

Awards Count

52

All time

Active

4

Currently performing

Completed

48

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$16.6M91.7%Department Of Health And Human Services (hhs)$760.2K4.2%Department Of Agriculture$714.8K3.9%

Other agencies (1 agencies, <0.5% each)$24.0K0.1%

Awards by NAICS

- Unknown NAICS$16.6M91.4%

541714 - Research and Development in Biotechnology (except Nanobiotechnology)$582.5K3.2%541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)$312.0K1.7%541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)$209.6K1.2%541711 - Research and Development in Biotechnology$200.6K1.1%325413 - In-Vitro Diagnostic Substance Manufacturing$179.0K1%

Others - Other NAICS codes (3 codes, <0.5% each)$75.2K0.4%

Awards by Agency Over Time

Awards by Place of Performance

Compete with IMMPORT THERAPEUTICS INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for IMMPORT THERAPEUTICS INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in IMMPORT THERAPEUTICS INC's top NAICS codes and agencies

U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)

Solicitation # W911PT26SC001

The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.

POSTED

about 19 hours ago

DEADLINE

"Provide specialized piping expertise overseeing the Craft Labor/Corrosion Control subcontractor for field modifications at KSC including but not limited to fabrication and installation of piping spool pieces, piping & tubing supports, flared & welded tub

Solicitation # 80NSSC26945986Q

NASA Shared Services Center

POSTED

about 19 hours ago

DEADLINE

Scientific Data Management and Publication SupportThe Scientific Data Management and Publication Support subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, focuses on the dissemination of data, tools, and technologies for prime contractors involved in NIDCD medical research projects. The selected provider will manage resource sharing between laboratories and the NIDCD, assist in the preparation of scientific publications, and implement NIH Data Management and Sharing plans. These tasks must be executed using statistical software and secure data repositories while maintaining strict adherence to NIH cybersecurity guidelines. The primary deliverables for this engagement include the provision of disseminated data sets and the completion of published research papers. This opportunity falls under NAICS code 541715 and has a response deadline of March 5, 2027.

National Institutes Of Health

POSTED

DEADLINE

MPS Platform Development & EngineeringThis subcontract focuses on the development and engineering of Microphysiological Systems and Organ-on-a-Chip platforms to support prime contractors on NIH/NIAID infectious disease projects. The scope of work involves engineering microfluidic devices, optimizing tissue-chip interfaces, and utilizing biocompatible polymers and precision pumps to integrate human variability into hardware and biological interfaces. The ultimate goal is to deliver a validated and reproducible platform that aligns with NIH and FDA guidance regarding New Approach Methodologies. Managed under the National Institutes of Health within the Department of Health and Human Services, the project falls under NAICS code 541714. The solicitation was posted on October 20, 2026, with a response deadline set for January 29, 2027.

National Institutes Of Health

POSTED

DEADLINE

Human Temporal Bone and Fresh Ear Tissue Processing LaboratoryThis subcontract for the National Institutes of Health involves the receiving and processing of human temporal bones and fresh ear tissue to support research network projects for the NIDCD. The selected provider will be responsible for obtaining specimens from the National Hearing and Balance Organ Donor Program, processing inner and middle ear tissues, scanning slides, and summarizing donor medical records. Final deliverables include the processed specimens, high-resolution scanned images, and comprehensive annotated data. To execute these tasks, the contractor must possess specialized high-resolution slide scanning equipment and maintain strict biohazard containment protocols. Additionally, the provider is required to maintain an active IRB certification throughout the duration of the project. This effort falls under NAICS code 541715 and is managed under the Department of Health and Human Services.

National Institutes Of Health

POSTED

DEADLINE

in about 1 year

Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)

Solicitation # RFA-DC-28-002

Solicitation RFA-DC-28-002 is a Notice of Funding Opportunity from the National Institutes of Health, specifically the National Institute on Deafness and Other Communication Disorders, to establish a Coordinating Center for the NIDCD National Human Ear Resource Network. This collaborative network provides human inner and middle ear tissues to researchers for basic and clinical studies aimed at advancing the treatment of auditory and vestibular disorders. The Coordinating Center is responsible for maintaining network cohesiveness through the planning of workshops, symposia, and regular meetings, providing updates to laboratories, and managing communication with the public and scientific community regarding tissue donation. The maximum project period is five years, with a budget limit of 200,000 dollars in direct costs per year. Applicants, including for-profit organizations and small businesses, must maintain active registrations in SAM, eRA Commons, and Grants.gov. Proposals are evaluated based on the significance of the proposed center and the qualifications of the investigators, with additional reviews for human subject protections, inclusion policies, and the use of vertebrate animals. Key requirements include a structured Data Management and Sharing Plan and adherence to cybersecurity guidelines, including a 48-hour incident reporting window. The application process is entirely electronic and requires several standard PHS and SF424 forms, with a response deadline of March 5, 2027.

National Institutes Of Health

POSTED

DEADLINE

National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)

Solicitation # RFA-DC-28-001

Solicitation RFA-DC-28-001 is a Notice of Funding Opportunity issued by the National Institutes of Health under the Department of Health and Human Services to support the NIDCD National Human Ear Resource Network. The objective is to maintain a collaborative network of laboratories that serve as a national technological resource, providing human inner and middle ear tissues to researchers for basic and clinical studies to advance the treatment of auditory and vestibular disorders. The scope of work includes processing human temporal bones from the National Hearing and Balance Organ Donor Program, uploading images and medical data to EarBase, sharing gene-expression data via the gEAR repository, and providing technical instruction to increase the number of skilled researchers in the field. The NIDCD intends to commit 3.6 million dollars in FY 2028 to fund up to six awards, with a maximum project period of five years. Individual awards are limited to 450,000 dollars in direct costs per year, with an additional 150,000 dollars available for specific subawards. Applications are due on March 05, 2027, and November 01, 2027, with staggered start dates ranging from July 2027 to July 2028. Evaluation is based on the experience of the investigators, the adequacy of the institutional environment, and the protection of human subjects. Applicants must maintain active SAM registration and a Unique Entity Identifier, and they must provide a Data Management and Sharing Plan and a Material Transfer Agreement. Compliance with the Cybersecurity Act of 2015 is required, including the development of an incident response plan and notification of cybersecurity incidents within 48 hours of discovery.

National Institutes Of Health

POSTED

DEADLINE

in about 1 year

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Solicitation # RFA-AI-28-012

The National Institute of Allergy and Infectious Diseases (NIAID) has issued solicitation RFA-AI-28-012 to establish a consortium of Translational Centers Using Microphysiological Systems for Infectious Diseases (TCMID). The primary objective is to refine and validate human tissue models using Microphysiological Systems (MPS) to a level consistent with regulatory qualifications, thereby promoting their adoption by product developers and reducing reliance on laboratory animals. This initiative aligns with NIH and FDA guidance on New Approach Methodologies (NAMs) to accelerate the development of safer medical interventions by capturing human variability and patient-specific characteristics. The program is structured around an Administrative Core, a Qualification Core, and Scientific Cores, with a heavy emphasis on technical readiness, reproducibility, and regulatory acceptance. Key deliverables include the validation of assays for specific endpoints and the submission of regulatory packages. Applicants must be domestic entities, as foreign organizations and foreign subawards are strictly prohibited. Required personnel must possess deep expertise in infectious diseases, MPS platforms, bioinformatics, and FDA submission processes. Applications are due by January 29, 2027, and must be submitted via the NIH ASSIST system or approved institutional system-to-system solutions. Evaluation is based on an overall impact score considering the project's significance, the suitability of the investigators, and the quality of the institutional environment. Mandatory application components include a Data Management and Sharing Plan and a Benchmarks and Timeline PDF not exceeding six pages. Awardees must also adhere to strict cybersecurity incident reporting guidelines, notifying HHS within 48 hours of any discovery.

National Institutes Of Health

POSTED

DEADLINE

Immune Tolerance Network (UM1 Clinical Trial Required)

Solicitation # RFA-AI-28-005

The National Institutes of Health, under the Department of Health and Human Services, is seeking applications through solicitation RFA-AI-28-005 to continue the Immune Tolerance Network (ITN). This cooperative agreement aims to develop tolerogenic therapies for immune-mediated disorders, specifically focusing on autoimmune diseases, allergic diseases and asthma, and the immune-mediated consequences of transplantation. The network operates through four integrated functional areas: Leadership, Clinical Operations, Core Laboratory, and Bioinformatics. Its primary objectives include designing and conducting clinical trials, performing integrated mechanistic studies, and sharing research results. Eligible applicants include small businesses and other for-profit organizations, though non-domestic entities are ineligible. Applications are evaluated based on scientific and technical merit, with a primary focus on significance and the likelihood of exerting a sustained influence on the research field. Key requirements include maintaining active registrations in SAM.gov, eRA Commons, and Grants.gov, as well as adhering to strict cybersecurity incident reporting and human subject protection protocols. The project requires a minimum effort of 3.6 person months per year for the PD/PI and mandates participation in a kick-off meeting in Bethesda, Maryland, and bi-annual steering meetings. Applications must follow specific page limits for the research strategy subsections and include detailed plans for clinical trial implementation, data management, and biorepository services.

National Institutes Of Health

POSTED

DEADLINE

Silviculture Growth & Yield Modelling SpecialistThe Silviculture Growth and Yield Modelling Specialist subcontract supports prime contractors on projects for the Province of British Columbia's Ministry of Forests. The selected specialist will perform advanced statistical analysis and growth and yield modelling, specifically utilizing the Mixedwood Growth Model to establish stocking standards for conifer, broadleaf, mixedwood, and successional forests. A primary objective of the role is the creation of algorithms designed to project stand attributes based on data gathered from free growing surveys. Candidates must possess advanced proficiency in statistical analysis software and extensive expertise with the Mixedwood Growth Model to successfully deliver the required projection algorithms and modelled results. This opportunity was posted on October 19, 2026, with a response deadline of October 29, 2026.

Ministry of Forests

POSTED

DEADLINE

Mental Health Screening Tool Array DesignThis subcontract, titled Mental Health Screening Tool Array Design, involves providing clinical content and validated screening tools to prime contractors working on Illinois State Board of Education projects. The primary objective is to develop specialized tool arrays capable of identifying childhood mental health challenges related to internalizing, externalizing, and trauma. To ensure clinical efficacy and legal compliance with Public Act 104-0032, the tools must be optimized for administration in under ten minutes. The final deliverable consists of a validated set of screening tools fully integrated into the designated platform. This project is managed under the Community Residential Services Authority for the state of Illinois.

COMRESSERVAUTH586 - Community Residential Services Authority

POSTED

DEADLINE

First To Know Syphilis Tests and Controls Sets

Solicitation # QQ-130085

The Virginia Department of Health is soliciting quotes for First To Know Syphilis Tests and Controls manufactured by NowDiagnostics. The procurement includes 241 units of the Syphilis test kits (Item 8057-1-12), 145 units of the Convenience Pack (Item 8057-25-CP), and Non-assayed Syphilis Control Sets (Item 457.012). The contract is structured with four one-year renewal options, and the desired delivery time is 14 calendar days after receipt of order to a location in Henrico, Virginia. Bidders must provide a certified test report from a recognized laboratory and submit all proposals through the eVA portal. Award priority is given to DSBSD-certified micro and small businesses, including women-owned and minority-owned firms, provided the pricing is determined to be fair and reasonable. Proposals must remain valid for 90 days, and contractors are required to maintain specific insurance coverages authorized by the Virginia State Corporation Commission. Key technical requirements include the provision of Material Safety Data Sheets and adherence to strict storage protocols for control sets, which must be refrigerated at 2–8°C and not frozen. Payment is contingent upon the completion of installation, testing, and acceptance by the agency, with a standard payment term of 30 days.

Virginia Department of Health

POSTED

DEADLINE

Notice of Correction to Award Information and Application and Submission Information for PA-27-037 "Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)"

Solicitation # NOT-OD-26-091

This notice provides corrections to the award and application information for the Predoctoral to Postdoctoral Transition Award (Parent F99/K00), specifically for solicitation NOT-OD-26-091 issued by the National Institutes of Health. The primary updates involve the removal of Kirschstein-NRSA support period limitations. Eligible individuals may now receive up to five years of aggregate support, consisting of up to two years at the F99 predoctoral level and up to three years at the K00 postdoctoral level. Additionally, the notice clarifies that a Certification Letter is no longer required for these applications, and corresponding instructions have been removed from the SF424(R&R) Other Project Information section. These changes are effective for the application due date of August 8, 2026. For further inquiries, the Division of Biomedical Research Workforce serves as the primary point of contact.

National Institutes Of Health Office Of The Director

POSTED

DEADLINE

Notice of NIBIB Participation in PA-27-037: Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)

Solicitation # NOT-EB-26-005

The National Institute of Biomedical Imaging and Bioengineering is joining the Predoctoral to Postdoctoral Transition Award (Parent F99/K00), effective for applications received on or after December 08, 2026. This funding opportunity is designed for researchers transitioning from predoctoral to postdoctoral training, provided that clinical trials are not involved. All submitted applications must align with the specific missions of the participating Institutes and Centers. This update expands the list of participating organizations and agency contacts to include the National Institute of Biomedical Imaging and Bioengineering and its Chief Grants Management Officer. The award is supported by a wide array of National Institutes of Health offices and centers, including the National Cancer Institute and the National Institute on Aging, among others. All other terms and conditions of the original notice of funding opportunity remain unchanged.

National Institute Of Biomedical Imaging And Bioengineering

POSTED

DEADLINE

Notice of FIC Participation in PA-26-002 "NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)"

Solicitation # NOT-TW-26-002

The Fogarty International Center is participating in the NIH Collaborative International Research Project, identified as PA-26-002. This funding opportunity is effective for applications submitted on or after January 25, 2027. The program is designed for collaborative international research projects and allows for optional clinical trials. A wide array of NIH Institutes and Centers are participating organizations, and applications must align with their specific missions. Additionally, the Office of Research on Women's Health, the INCLUDE Project, and the Office of Data Science Strategy may provide co-funding for assigned applications. All other terms and conditions of the original notice of funding opportunity remain unchanged.

POSTED

DEADLINE

Thermal Performance & Dielectric Testing LaboratoryThis subcontract opportunity is for a Thermal Performance and Dielectric Testing Laboratory to provide independent testing and validation services for prime contractors supporting USAF AFLCMC/WAR F-22 cooling fluid projects. The selected provider will be responsible for evaluating low-temperature viscosity, high-temperature stability, and dielectric strength utilizing specialized equipment such as viscosity meters and stability chambers. The final deliverables for this engagement include comprehensive technical test reports and performance validation data. To be eligible, the contractor must be a domestic U.S. company and hold ISO/IEC 17025 accreditation. The work is associated with NAICS code 541715 and will be performed at Wright Patterson AFB. Interested parties must submit their responses by November 3, 2026.

FA8611 Aflcmc Wauk F22

POSTED

DEADLINE

Certified Industrial Wastewater Laboratory TestingThis subcontract opportunity is for certified industrial wastewater laboratory testing to support prime contractors on Department of Veterans Affairs Medical Center projects located in Huntington, West Virginia. The selected provider will be responsible for analyzing wastewater samples for Total Phenolics, Oil and Grease, Flashpoint, Acrolein, and a full list of Volatile Organic Compounds. All testing must be conducted using EPA analytical procedures as specified in 40 CFR Part 136, and the provider must deliver formal certified laboratory analysis reports. To be eligible, the contractor must hold a valid State of West Virginia certification for wastewater testing and possess specialized instrumentation required for VOC detection. This requirement falls under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 5. Interested parties should note the response deadline of November 16, 2026.

245-NETWORK Contract Office 5 (36C245)

POSTED

DEADLINE

Clinical Trial Management (Phase I/II)This subcontract opportunity involves the management and execution of Phase I and Phase II clinical trials supporting US Army JPM CBRN Medical projects. The selected provider will be responsible for conducting human safety trials, collecting pharmacokinetic and pharmacodynamic observations, and managing biomarker or human challenge data. Key deliverables include comprehensive clinical trial reports and detailed safety findings to support the development of medical countermeasures. The project requires a partner with established Clinical Research Organization capabilities and specific experience navigating defense-related medical protocols. Performance will take place in Frederick, Maryland, under the oversight of the Department of Defense. Interested parties must submit their responses by November 18, 2026, in accordance with the solicitation posted on October 19, 2026.

POSTED

DEADLINE